Immunosuppressive disease is independently associated with significantly shorter survival among patients with CSCC receiving ICI therapy.

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ...

Ivarmacitinib is associated with favorable treatment outcomes in patients with moderate to severe AD across subgroups with diverse characteristics.

Results of a national sample reveal that more than 82 million Americans made at least 1 trade-off in the past year to pay for health care.

For children with atopic dermatitis (AD), dupilumab treatment restores skin barrier function, according to a study published ...

Clinicians should consider the logistical requirements and ethical implications of concierge medicine before adopting this ...

Vaccine-induced protection against HPV-related genital disease may be strong among men, supporting its role in equitable and ...

A federal judge has stopped a major effort to change the nation’s childhood vaccine schedule. The ruling, issued Monday in Massachusetts, blocks U.S. Health S ...

Researchers explored the effect of immune checkpoint inhibitors on psoas muscle density and skeletal muscle index in patients ...

Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...

HealthDay News — Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at ...

Mycophenolate mofetil is associated with comparable treatment outcomes to methotrexate among patients with juvenile localized ...